PCSK9

After the close on Monday, Amgen, Inc. (NASDAQ: AMGN) announced that the U.S. District Court of Delaware had denied the motion by Sanofi SA (ADR) (NYSE: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to stay the injunction pending the appeal of the ongoing PCSK9 litigation in the Court of...

Gbola Amusa, Chardan Capital Markets' head of healthcare research, commented in a note on Monday that investors should be "more selective" in the biotech space. As such, the analyst downgraded shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to Neutral from Buy with an unchanged $565 price...

Biotech stocks are among the most volatile and investors are constantly looking towards Wall Street for top notch research and analysis. Michael King of JMP Securities hosted an investor call with Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)'s management team and discussed revusiran...

Shares of The Medicines Company (NASDAQ: MDCO) tumbled more than 5 percent Wednesday after the company reported its second-quarter results before the market opened. Shares opened the day for trading at $32.77 and quickly moved lower to $31.08 before slightly rebounding. Umer Raffat, Evercore ISI's...